Please enable Javascript

Labmeeting uses lots of Javascript - basically you can't use the site without it. So please enable Javascript in your browser. If your browser does not support Javascript, we recommend Firefox.

Papers authored by Tsimberidou AM

Collect these papers and discover other ones on Labmeeting. Learn more.

Phase I clinical trials in 56 patients with thyroid cancer: the m. D. Anderson cancer center experience.

+ cite this

+ View Abstract

Tsimberidou AM, Vaklavas C, Wen S, Hong D, Wheler J, Ng C, Naing A, Tse S, Busaidy N, Markman M, Sherman SI, and Kurzrock R

The Journal of clinical endocrinology and metabolism 94(11):4423-32, 2009 Nov - Who cited this? | PubMed ID: 19820016 | Fulltext

Pediatric therapy-related myelodysplastic syndrome/acute myeloid leukemia: the MD Anderson Cancer Center experience.

+ cite this

+ View Abstract

Aguilera DG, Vaklavas C, Tsimberidou AM, Wen S, Medeiros LJ, and Corey SJ

Journal of pediatric hematology/oncology : official journal of the American Society of Pediatric Hematology/Oncology 31(11):803-11, 2009 Nov - Who cited this? | PubMed ID: 19801947 | Fulltext

A phase I clinical trial of darinaparsin in patients with refractory solid tumors.

+ cite this

+ View Abstract

Tsimberidou AM, Camacho LH, Verstovsek S, Ng C, Hong DS, Uehara CK, Gutierrez C, Daring S, Stevens J, Komarnitsky PB, Schwartz B, and Kurzrock R

Clinical cancer research : an official journal of the American Association for Cancer Research 15(14):4769-76, 2009 Jul 15 - Who cited this? | PubMed ID: 19584162 | Fulltext

Treatment of fludarabine-refractory chronic lymphocytic leukemia.

+ cite this

+ View Abstract

Tsimberidou AM and Keating MJ

Cancer 115(13):2824-36, 2009 Jul 1 - Who cited this? | PubMed ID: 19402170 | Fulltext

Clinical outcomes and factors predicting development of venous thromboembolic complications in patients with advanced refractory cancer in a Phase I Clinic: the M. D. Anderson Cancer Center experience.

+ cite this

+ View Abstract

Vemulapalli S, Chintala L, Tsimberidou AM, Dhillon N, Lei X, Hong D, and Kurzrock R

American journal of hematology 84(7):408-13, 2009 Jul - Who cited this? | PubMed ID: 19437507 | Fulltext

Dasatinib in chronic myeloid leukemia: a review.

+ cite this

+ View Abstract

Aguilera DG and Tsimberidou AM

Therapeutics and clinical risk management 5(2):281-9, 2009 Apr - Who cited this? | PubMed ID: 19536317 | Fulltext

Survival of patients in a Phase 1 clinic: the M. D. Anderson Cancer Center Experience.

+ cite this

+ View Abstract

Wheler J, Tsimberidou AM, Hong D, Naing A, Jackson T, Liu S, Feng L, and Kurzrock R

Cancer 115(5):1091-9, 2009 Mar 1 - Who cited this? | PubMed ID: 19165805 | Fulltext

Other malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma.

+ cite this

+ View Abstract

Tsimberidou AM, Wen S, McLaughlin P, O'Brien S, Wierda WG, Lerner S, Strom S, Freireich EJ, Medeiros LJ, Kantarjian HM, and Keating MJ

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 27(6):904-10, 2009 Feb 20 - Who cited this? | PubMed ID: 19114699 | Fulltext

Chemoimmunotherapy may overcome the adverse prognostic significance of 11q deletion in previously untreated patients with chronic lymphocytic leukemia.

+ cite this

+ View Abstract

Tsimberidou AM, Tam C, Abruzzo LV, O'Brien S, Wierda WG, Lerner S, Kantarjian HM, and Keating MJ

Cancer 115(2):373-80, 2009 Jan 15 - Who cited this? | PubMed ID: 19117034 | Fulltext

Myeloid sarcoma is associated with superior event-free survival and overall survival compared with acute myeloid leukemia.

+ cite this

+ View Abstract

Tsimberidou AM, Kantarjian HM, Wen S, Keating MJ, O'Brien S, Brandt M, Pierce S, Freireich EJ, Medeiros LJ, and Estey E

Cancer 113(6):1370-8, 2008 Sep 15 - Who cited this? | PubMed ID: 18623376 | Fulltext

Relevance of clinical trials in acute myeloid leukaemia.

+ cite this

+ View Abstract

Tsimberidou AM and Estey E

Hematological oncology 26(3):182-3, 2008 Sep - Who cited this? | PubMed ID: 18381703 | Fulltext

The prognostic significance of cytokine levels in newly diagnosed acute myeloid leukemia and high-risk myelodysplastic syndromes.

+ cite this

+ View Abstract

Tsimberidou AM, Estey E, Wen S, Pierce S, Kantarjian H, Albitar M, and Kurzrock R

Cancer, 2008 Aug 5 - Who cited this? | PubMed ID: 18683214 | Fulltext

The Prognostic Significance of Serum {beta}2 Microglobulin Levels in Acute Myeloid Leukemia and Prognostic Scores Predicting Survival: Analysis of 1,180 Patients.

+ cite this

+ View Abstract

Tsimberidou AM, Kantarjian HM, Wen S, O'Brien S, Cortes J, Wierda WG, Koller C, Pierce S, Brandt M, Freireich EJ, Keating MJ, and Estey EH

Clinical cancer research : an official journal of the American Association for Cancer Research 14(3):721-30, 2008 Feb 1 - Who cited this? | PubMed ID: 18245532 | Fulltext

Phase I-II study of oxaliplatin, fludarabine, cytarabine, and rituximab combination therapy in patients with richter's syndrome or fludarabine-refractory chronic lymphocytic leukemia.

+ cite this

+ View Abstract

Tsimberidou AM, Wierda WG, Plunkett W, Kurzrock R, O'Brien S, Wen S, Ferrajoli A, Ravandi-Kashani F, Garcia-Manero G, Estrov Z, Kipps TJ, Brown JR, Fiorentino A, Lerner S, Kantarjian HM, and Keating MJ

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 26(2):196-203, 2008 Jan 10 - Who cited this? | PubMed ID: 18182662 | Fulltext

Assessment of chronic lymphocytic leukemia and small lymphocytic lymphoma by absolute lymphocyte counts in 2,126 patients: 20 years of experience at the University of Texas M.D. Anderson Cancer Center.

+ cite this

+ View Abstract

Tsimberidou AM, Wen S, O'Brien S, McLaughlin P, Wierda WG, Ferrajoli A, Faderl S, Manning J, Lerner S, Mai CV, Rodriguez AM, Hess M, Do KA, Freireich EJ, Kantarjian HM, Medeiros LJ,

(show remaining authors)

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 25(29):4648-56, 2007 Oct 10 - Who cited this? | PubMed ID: 17925562 | Fulltext

The natural history of fludarabine-refractory chronic lymphocytic leukemia patients who fail alemtuzumab or have bulky lymphadenopathy.

+ cite this

+ View Abstract

Tam CS, O'Brien S, Lerner S, Khouri I, Ferrajoli A, Faderl S, Browning M, Tsimberidou AM, Kantarjian H, and Wierda WG

Leukemia & lymphoma 48(10):1931-9, 2007 Oct - Who cited this? | PubMed ID: 17917961 | Fulltext

Anaplastic large cell lymphoma with involvement of the pancreas presenting as panniculitis in a patient with a history of acute myeloid leukemia--case report and review of the literature.

+ cite this

+ View Abstract

Ahmed B, Estey E, Manning J, David C, Keating MJ, Kantarjian H, and Tsimberidou AM

Haematologica 91(12 Suppl):ECR55, 2006 Dec - Who cited this? | PubMed ID: 17194661 | Fulltext

Optimizing treatment for elderly patients with acute promyelocytic leukemia: is it time to replace chemotherapy with all-trans retinoic acid and arsenic trioxide?.

+ cite this

+ View Abstract

Tsimberidou AM, Kantarjian H, Keating MJ, and Estey E

Leukemia & lymphoma 47(11):2282-8, 2006 Nov - Who cited this? | PubMed ID: 17107899 | Fulltext

Hodgkin transformation of chronic lymphocytic leukemia: the M. D. Anderson Cancer Center experience.

+ cite this

+ View Abstract

Tsimberidou AM, O'Brien S, Kantarjian HM, Koller C, Hagemeister FB, Fayad L, Lerner S, Bueso-Ramos CE, and Keating MJ

Cancer 107(6):1294-302, 2006 Sep 15 - Who cited this? | PubMed ID: 16902984 | Fulltext

Granulocyte colony stimulating factor administration associated with cerebral hemorrhage in acute promyelocytic leukemia.

+ cite this

Tsimberidou AM, Estey E, Kantarjian H, Keating MJ, Pierce S, and Garcia-Manero G

Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 20(8):1452-3, 2006 Aug - Who cited this? | PubMed ID: 16728980 | Fulltext

Detection of Richter's transformation of chronic lymphocytic leukemia by PET/CT.

+ cite this

+ View Abstract

Bruzzi JF, Macapinlac H, Tsimberidou AM, Truong MT, Keating MJ, Marom EM, and Munden RF

Journal of nuclear medicine : official publication, Society of Nuclear Medicine 47(8):1267-73, 2006 Aug - Who cited this? | PubMed ID: 16883004 | Fulltext

Outcomes in patients with splenic marginal zone lymphoma and marginal zone lymphoma treated with rituximab with or without chemotherapy or chemotherapy alone.

+ cite this

+ View Abstract

Tsimberidou AM, Catovsky D, Schlette E, O'Brien S, Wierda WG, Kantarjian H, Garcia-Manero G, Wen S, Do KA, Lerner S, and Keating MJ

Cancer 107(1):125-35, 2006 Jul 1 - Who cited this? | PubMed ID: 16700034 | Fulltext

Induction mortality risk in adult acute myeloid leukemia.

+ cite this

Tsimberidou AM and Estey E

Leukemia & lymphoma 47(7):1199-200, 2006 Jul - Who cited this? | PubMed ID: 16923545 | Fulltext

Single-agent liposomal all-trans retinoic acid can cure some patients with untreated acute promyelocytic leukemia: an update of The University of Texas M. D. Anderson Cancer Center Series.

+ cite this

+ View Abstract

Tsimberidou AM, Tirado-Gomez M, Andreeff M, O'Brien S, Kantarjian H, Keating M, Lopez-Berestein G, and Estey E

Leukemia & lymphoma 47(6):1062-8, 2006 Jun - Who cited this? | PubMed ID: 16840198 | Fulltext

Clinical outcomes and prognostic factors in patients with Richter's syndrome treated with chemotherapy or chemoimmunotherapy with or without stem-cell transplantation.

+ cite this

+ View Abstract

Tsimberidou AM, O'Brien S, Khouri I, Giles FJ, Kantarjian HM, Champlin R, Wen S, Do KA, Smith SC, Lerner S, Freireich EJ, and Keating MJ

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 24(15):2343, 2006 May 20 - Who cited this? | PubMed ID: 16710033 | Fulltext

Myeloid sarcoma involving the gynecologic tract: a report of 11 cases and review of the literature.

+ cite this

+ View Abstract

Garcia MG, Deavers MT, Knoblock RJ, Chen W, Tsimberidou AM, Manning JT, and Medeiros LJ

American journal of clinical pathology 125(5):783-90, 2006 May - Who cited this? | PubMed ID: 16707383 | Fulltext

Epstein-Barr virus in patients with chronic lymphocytic leukemia: a pilot study.

+ cite this

+ View Abstract

Tsimberidou AM, Keating MJ, Bueso-Ramos CE, and Kurzrock R

Leukemia & lymphoma 47(5):827-36, 2006 May - Who cited this? | PubMed ID: 16753866 | Fulltext

Improvement of overall and failure-free survival in stage IV follicular lymphoma: 25 years of treatment experience at The University of Texas M.D. Anderson Cancer Center.

+ cite this

+ View Abstract

Liu Q, Fayad L, Cabanillas F, Hagemeister FB, Ayers GD, Hess M, Romaguera J, Rodriguez MA, Tsimberidou AM, Verstovsek S, Younes A, Pro B, Lee MS, Ayala A, and McLaughlin P

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 24(10):1582, 2006 Apr 1 - Who cited this? | PubMed ID: 16575009 | Fulltext

Richter's transformation in chronic lymphocytic leukemia.

+ cite this

+ View Abstract

Tsimberidou AM and Keating MJ

Seminars in oncology 33(2):250-6, 2006 Apr - Who cited this? | PubMed ID: 16616072 | Fulltext

The role of gemtuzumab ozogamicin in acute leukaemia therapy.

+ cite this

+ View Abstract

Tsimberidou AM, Giles FJ, Estey E, O'Brien S, Keating MJ, and Kantarjian HM

British journal of haematology 132(4):398-409, 2006 Feb - Who cited this? | PubMed ID: 16412015 | Fulltext

Immunosuppression and infectious complications in patients with stage IV indolent lymphoma treated with a fludarabine, mitoxantrone, and dexamethasone regimen.

+ cite this

+ View Abstract

Tsimberidou AM, Younes A, Romaguera J, Hagemeister FB, Rodriguez MA, Feng L, Ayala A, Smith TL, Cabanillas F, and McLaughlin P

Cancer 104(2):345-53, 2005 Jul 15 - Who cited this? | PubMed ID: 15948158 | Fulltext

Adaptive randomized study of idarubicin and cytarabine alone or with interleukin-11 as induction therapy in patients aged 50 or above with acute myeloid leukemia or high-risk myelodysplastic syndromes.

+ cite this

+ View Abstract

Giles FJ, Kantarjian HM, Cortes JE, Faderl S, Verstovsek S, Thomas D, Garcia-Manero G, Wierda W, Ferrajoli A, Kornblau S, Mattiuzzi GN, Tsimberidou AM, Albitar M, O'Brien SM, and Estey E

Leukemia research 29(6):649-52, 2005 Jun - Who cited this? | PubMed ID: 15863204 | Fulltext

Potential curability of newly diagnosed acute promyelocytic leukemia without use of chemotherapy: the example of liposomal all-trans retinoic acid.

+ cite this

Estey E, Koller C, Tsimberidou AM, O'Brien S, Beran M, Cortes J, Tirado-Gomez M, Lopez-Berestein G, and Kantarjian H

Blood 105(3):1366-7, 2005 Feb 1 - Who cited this? | PubMed ID: 15659618 | Fulltext

Richter syndrome: biology, incidence, and therapeutic strategies.

+ cite this

+ View Abstract

Tsimberidou AM and Keating MJ

Cancer 103(2):216-28, 2005 Jan 15 - Who cited this? | PubMed ID: 15578683 | Fulltext

Low-dose interleukin-11 in patients with bone marrow failure: update of the M. D. Anderson Cancer Center experience.

+ cite this

+ View Abstract

Tsimberidou AM, Giles FJ, Khouri I, Bueso-Ramos C, Pilat S, Thomas DA, Cortes J, and Kurzrock R

Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 16(1):139-45, 2005 Jan - Who cited this? | PubMed ID: 15598951 | Fulltext

Hyperuricemic syndromes in cancer patients.

+ cite this

+ View Abstract

Tsimberidou AM and Keating MJ

Contributions to nephrology 147:47-60, 2005 - Who cited this? | PubMed ID: 15604605 | Fulltext

Extramedullary relapse in a patient with acute promyelocytic leukemia: successful treatment with arsenic trioxide, all-trans retinoic acid and gemtuzumab ozogamicin therapies.

+ cite this

+ View Abstract

Tsimberidou AM, Estey E, Whitman GJ, Dryden MJ, Ratnam S, Pierce S, Faderl S, Giles F, Kantarjian HM, and Garcia-Manero G

Leukemia research 28(9):991-4, 2004 Sep - Who cited this? | PubMed ID: 15234578 | Fulltext

Pilot study of etanercept in patients with relapsed cutaneous T-cell lymphomas.

+ cite this

+ View Abstract

Tsimberidou AM, Giles FJ, Duvic M, and Kurzrock R

Journal of the American Academy of Dermatology 51(2):200-4, 2004 Aug - Who cited this? | PubMed ID: 15280837 | Fulltext

Fludarabine and mitoxantrone for patients with chronic lymphocytic leukemia.

+ cite this

+ View Abstract

Tsimberidou AM, Keating MJ, Giles FJ, Wierda WG, Ferrajoli A, Lerner S, Beran M, Andreeff M, Kantarjian HM, and O'Brien S

Cancer 100(12):2583-91, 2004 Jun 15 - Who cited this? | PubMed ID: 15197800 | Fulltext

Chronic myeloid leukemia in a patient with acquired immune deficiency syndrome: complete cytogenetic response with imatinib mesylate: report of a case and review of the literature.

+ cite this

+ View Abstract

Tsimberidou AM, Medina J, Cortes J, Rios A, Bonnie G, Faderl S, Kantarjian H, and Garcia-Manero G

Leukemia research 28(6):657-60, 2004 Jun - Who cited this? | PubMed ID: 15120945 | Fulltext

Yttrium-90 ibritumomab tiuxetan radioimmunotherapy in Richter syndrome.

+ cite this

+ View Abstract

Tsimberidou AM, Murray JL, O'Brien S, Wierda WG, and Keating MJ

Cancer 100(10):2195-200, 2004 May 15 - Who cited this? | PubMed ID: 15139064 | Fulltext

Activity of interferon-alpha and isotretinoin in patients with advanced, refractory lymphoid malignancies.

+ cite this

+ View Abstract

Tsimberidou AM, Giles F, Romaguera J, Duvic M, and Kurzrock R

Cancer 100(3):574-80, 2004 Feb 1 - Who cited this? | PubMed ID: 14745875 | Fulltext

Phase II study of pentostatin in advanced T-cell lymphoid malignancies: update of an M.D. Anderson Cancer Center series.

+ cite this

+ View Abstract

Tsimberidou AM, Giles F, Duvic M, Fayad L, and Kurzrock R

Cancer 100(2):342-9, 2004 Jan 15 - Who cited this? | PubMed ID: 14716770 | Fulltext

Mylotarg, fludarabine, cytarabine (ara-C), and cyclosporine (MFAC) regimen as post-remission therapy in acute myelogenous leukemia.

+ cite this

+ View Abstract

Tsimberidou AM, Estey E, Cortes JE, Garcia-Manero G, Faderl S, Verstovsek S, Thomas DA, Ferrajoli A, Keating MJ, O'Brien S, Kantarjian HM, and Giles FJ

Cancer chemotherapy and pharmacology 52(6):449-52, 2003 Dec - Who cited this? | PubMed ID: 13680159 | Fulltext

Antithymocyte globulin (ATG)-based therapy in patients with myelodysplastic syndromes.

+ cite this

+ View Abstract

Yazji S, Giles FJ, Tsimberidou AM, Estey EH, Kantarjian HM, O'Brien SA, and Kurzrock R

Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 17(11):2101-6, 2003 Nov - Who cited this? | PubMed ID: 12931212 | Fulltext

Anti-B4 blocked ricin post chemotherapy in patients with chronic lymphocytic leukemia--long-term follow-up of a monoclonal antibody-based approach to residual disease.

+ cite this

+ View Abstract

Tsimberidou AM, Giles FJ, Kantarjian HM, Keating MJ, and O'Brien SM

Leukemia & lymphoma 44(10):1719-25, 2003 Oct - Who cited this? | PubMed ID: 14692524 | Fulltext

Anagrelide and imatinib mesylate combination therapy in patients with chronic myeloproliferative disorders.

+ cite this

+ View Abstract

Tsimberidou AM, Colburn DE, Welch MA, Cortes JE, Verstovsek S, O'Brien SM, Albitar M, Kantarjian HM, and Giles FJ

Cancer chemotherapy and pharmacology 52(3):229-34, 2003 Sep - Who cited this? | PubMed ID: 12783207 | Fulltext

Outcome in patients with nonleukemic granulocytic sarcoma treated with chemotherapy with or without radiotherapy.

+ cite this

+ View Abstract

Tsimberidou AM, Kantarjian HM, Estey E, Cortes JE, Verstovsek S, Faderl S, Thomas DA, Garcia-Manero G, Ferrajoli A, Manning JT, Keating MJ, Albitar M, O'Brien S, and Giles FJ

Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 17(6):1100-3, 2003 Jun - Who cited this? | PubMed ID: 12764375 | Fulltext

Pilot study of recombinant human soluble tumor necrosis factor (TNF) receptor (p75) fusion protein (TNFR:Fc; Enbrel) in patients with refractory multiple myeloma: increase in plasma TNF alpha levels during treatment.

+ cite this

+ View Abstract

Tsimberidou AM, Waddelow T, Kantarjian HM, Albitar M, and Giles FJ

Leukemia research 27(5):375-80, 2003 May - Who cited this? | PubMed ID: 12620287 | Fulltext

Fractionated cyclophosphamide, vincristine, liposomal daunorubicin, and dexamethasone plus rituximab and granulocyte-macrophage-colony stimulating factor (GM-CSF) alternating with methotrexate and cytarabine plus rituximab and GM-CSF in patients with Richter syndrome or fludarabine-refractory chronic lymphocytic leukemia.

+ cite this

+ View Abstract

Tsimberidou AM, Kantarjian HM, Cortes J, Thomas DA, Faderl S, Garcia-Manero G, Verstovsek S, Ferrajoli A, Wierda W, Alvarado Y, O'Brien SM, Albitar M, Keating MJ, and Giles FJ

Cancer 97(7):1711-20, 2003 Apr 1 - Who cited this? | PubMed ID: 12655528 | Fulltext

Search Google Scholar for Tsimberidou AM

Join Labmeeting

Organize and search your PDF collection
Collect papers
Search millions of papers
Keep up to date with paper alerts
Read your papers from anywhere
Recommend papers to colleagues
Manage your lab

Labmeeting is a web service for researchers. Sign up with your academic email address.

Individuals or corporations not affiliated with an academic institution can request a trial subscription.

Got a question?
The Labmeeting Network
has the answer.
Ask scientists at top universities like Harvard, Stanford, and MIT for their expert opinion!